Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Stands Firm On ANDA Stability Guidance’s 2014 Enforcement Deadline

Executive Summary

The generic industry is frustrated that the final version of the stability testing guidance has yet to be released, but FDA says the document is coming; the agency offered guidance clarification at a recent meeting and said it will enforce the guidance in January whether manufacturers are ready or not.

Advertisement

Related Content

ANDAs To Include Six Months Of Stability Test Data Under FDA Draft Guidance

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055421

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel